1. Home
  2. PHAR vs CCNE Comparison

PHAR vs CCNE Comparison

Compare PHAR & CCNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

N/A

Current Price

$17.49

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Logo CNB Financial Corporation

CCNE

CNB Financial Corporation

N/A

Current Price

$27.14

Market Cap

736.3M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
PHAR
CCNE
Founded
1988
1865
Country
Netherlands
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
736.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PHAR
CCNE
Price
$17.49
$27.14
Analyst Decision
Strong Buy
Hold
Analyst Count
2
1
Target Price
$38.00
$29.00
AVG Volume (30 Days)
23.0K
137.3K
Earning Date
11-06-2025
01-27-2026
Dividend Yield
N/A
2.65%
EPS Growth
N/A
N/A
EPS
0.00
1.91
Revenue
$362,274,000.00
$227,923,000.00
Revenue This Year
$25.19
$13.84
Revenue Next Year
$4.47
$27.68
P/E Ratio
$3,089.47
$14.22
Revenue Growth
26.78
5.27
52 Week Low
$7.50
$19.32
52 Week High
$18.12
$28.04

Technical Indicators

Market Signals
Indicator
PHAR
CCNE
Relative Strength Index (RSI) 54.02 58.29
Support Level $16.15 $27.55
Resistance Level $17.00 $28.01
Average True Range (ATR) 0.75 0.46
MACD -0.06 -0.07
Stochastic Oscillator 51.78 42.45

Price Performance

Historical Comparison
PHAR
CCNE

About PHAR Pharming Group N.V.

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.

About CCNE CNB Financial Corporation

CNB Financial Corp is providing integrated financial solutions, which create value for both consumers and businesses. These solutions encompass deposit accounts, private banking, real estate, commercial, industrial, residential and consumer loans and lines of credit, credit cards, treasury services, online banking, mobile banking, merchant credit card processing, remote deposit and accounts receivable handling. It derives revenue through the operations as a full-service bank engaging in a full range of banking activities and services, including trust and wealth management services, for individual, business, governmental, and institutional customers. The company branch are located in Pennsylvania, Ohio, New York and Virginia.

Share on Social Networks: